{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:53:42Z","timestamp":1790024022869,"version":"4.0.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1053\/j.semnuclmed.2025.11.024","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T20:22:05Z","timestamp":1765657325000},"page":"97-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["PET-CT radiomics for immunotherapy response"],"prefix":"10.1053","volume":"56","author":[{"given":"Alessia","family":"Artesani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Olivieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9150-4367","authenticated-orcid":false,"given":"Priscilla","family":"Guglielmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Marenco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5955-9488","authenticated-orcid":false,"given":"Laura","family":"Evangelista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0001","article-title":"The role of immune checkpoint inhibitors in cancer therapy: mechanism and therapeutic advances","volume":"6","author":"Chen","year":"2025","journal-title":"MedComm (Beijing)"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0002","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/annonc\/mdz003","article-title":"Novel patterns of response under immunotherapy","volume":"30","author":"Borcoman","year":"2019","journal-title":"Annal Oncol"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0003","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41571-018-0111-2","article-title":"Hyperprogressive disease: recognizing a novel pattern to improve patient management","volume":"15","author":"Champiat","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0004","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1158\/1078-0432.CCR-16-1741","article-title":"Hyperprogressive disease is a new pattern of progression in cancer patients treated by Anti-PD-1\/PD-L1","volume":"23","author":"Champiat","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0005","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s40336-022-00522-8","article-title":"Comparing [18F]FDG PET\/CT response criteria in melanoma and lung cancer patients treated with immunotherapy: a systematic review","volume":"10","author":"Saadani","year":"2022","journal-title":"Clin Transl Imaging"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0006","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s40336-023-00614-z","article-title":"Lymphoid organs\u2019 metabolism and its role in predicting the outcomes of patients with malignant melanoma treated with immunotherapy: an exploratory study","volume":"12","author":"De Rimini","year":"2024","journal-title":"Clin Transl Imaging"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0007","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.3390\/s22135044","article-title":"Form factors as potential imaging biomarkers to differentiate benign vs. malignant lung lesions on CT scans","volume":"22","author":"Bianconi","year":"2022","journal-title":"Sensors"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0008","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.3390\/diagnostics12102448","article-title":"Prediction of the presence of targetable molecular alteration(s) with clinico-metabolic 18 F-FDG PET radiomics in Non-Asian lung adenocarcinoma patients","volume":"12","author":"Aide","year":"2022","journal-title":"Diagnostics"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0009","doi-asserted-by":"crossref","first-page":"6095","DOI":"10.3390\/cancers14246095","article-title":"Predictive value of baseline FDG-PET\/CT for the durable response to immune checkpoint inhibition in NSCLC patients using the morphological and metabolic features of primary tumors","volume":"14","author":"Kudura","year":"2022","journal-title":"Cancer (Basel)"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0010","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/MNM.0000000000001025","article-title":"18F-FDG PET\/CT in non-small-cell lung cancer patients","volume":"40","author":"Evangelista","year":"2019","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0011","doi-asserted-by":"crossref","DOI":"10.1007\/s40336-023-00542-y","article-title":"FDG-PET metrics in advanced non-small cell lung cancer (NSCLC): a review and meta-analysis","author":"Berkowitz","year":"2023","journal-title":"Clin Transl Imaging"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0012","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","article-title":"Radiomics: extracting more information from medical images using advanced feature analysis","volume":"48","author":"Lambin","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0013","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1148\/radiol.2015151169","article-title":"Radiomics: Images are more than pictures, they are data","volume":"278","author":"Gillies","year":"2016","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0014","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.phro.2021.10.007","article-title":"A systematic review and quality of reporting checklist for repeatability and reproducibility of radiomic features","volume":"20","author":"Pfaehler","year":"2021","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0015","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2967\/jnumed.121.262464","article-title":"A guide to ComBat harmonization of imaging biomarkers in multicenter studies","volume":"63","author":"Orlhac","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0016","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","article-title":"Radiomics: the bridge between medical imaging and personalized medicine","volume":"14","author":"Lambin","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0017","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40658-018-0226-7","article-title":"Feasibility of PET\/CT system performance harmonisation for quantitative multicentre 89Zr studies","volume":"5","author":"Kaalep","year":"2018","journal-title":"EJNMMI Phys"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0018","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2967\/jnumed.116.184655","article-title":"Radiomics in PET\/CT: more than meets the eye?","volume":"58","author":"Hatt","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejro.2023.100511","article-title":"Delta-radiomics in cancer immunotherapy response prediction: a systematic review","volume":"11","author":"Abbas","year":"2023","journal-title":"Eur J Radiol Open"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0020","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1148\/radiol.2020191145","article-title":"The image biomarker standardization Initiative: standardized quantitative radiomics for high-throughput image-based phenotyping","volume":"295","author":"Zwanenburg","year":"2020","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0021","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40658-015-0116-1","article-title":"A novel phantom technique for evaluating the performance of PET auto-segmentation methods in delineating heterogeneous and irregular lesions","volume":"2","author":"Berthon","year":"2015","journal-title":"EJNMMI Phys"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0022","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1053\/j.semnuclmed.2022.04.010","article-title":"FDG PET\/CT for evaluation of immunotherapy response in lung cancer patients","volume":"52","author":"L\u00e9ger","year":"2022","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0023","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/annonc\/mdx034","article-title":"Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology","volume":"28","author":"Limkin","year":"2017","journal-title":"Annal Oncol"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0024","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s12149-021-01586-8","article-title":"Prognostic value of tumor metabolic imaging phenotype by FDG PET radiomics in HNSCC","volume":"35","author":"Yoon","year":"2021","journal-title":"Ann Nucl Med"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0025","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2967\/jnumed.117.199935","article-title":"A postreconstruction harmonization method for Multicenter radiomic studies in PET","volume":"59","author":"Orlhac","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0026","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.3390\/cancers15123258","article-title":"PET radiomics and response to immunotherapy in lung cancer: a systematic review of the literature","volume":"15","author":"Evangelista","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0027","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.ijrobp.2018.05.053","article-title":"Repeatability and reproducibility of radiomic features: a systematic review","volume":"102","author":"Traverso","year":"2018","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0028","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69298-z","article-title":"Standardization of brain MR images across machines and protocols: bridging the gap for MRI-based radiomics","volume":"10","author":"Carr\u00e9","year":"2020","journal-title":"Sci Rep"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0029","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1038\/s41598-019-40437-5","article-title":"The complexity of tumor shape, spiculatedness, correlates with tumor radiomic shape features","volume":"9","author":"Limkin","year":"2019","journal-title":"Sci Rep"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0030","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41698-024-00534-9","article-title":"A whirl of radiomics-based biomarkers in cancer immunotherapy, why is large scale validation still lacking?","volume":"8","author":"Ligero","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.crad.2025.106915","article-title":"Prediction of PD-L1 expression in NSCLC patients using PET\/CT radiomics and prognostic modelling for immunotherapy in PD-L1-positive NSCLC patients","volume":"86","author":"Peng","year":"2025","journal-title":"Clin Radiol"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0032","article-title":"Predicting PD-L1 in lung adenocarcinoma using 18F-FDG PET\/CT radiomic features","volume":"15","author":"Zhang","year":"2025","journal-title":"Diagnost (Basel)"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0033","doi-asserted-by":"crossref","first-page":"10094","DOI":"10.1245\/s10434-025-18139-2","volume":"32","author":"Ji","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0034","article-title":"Predicting PD-L1 expression status in NSCLC using radiomic analysis of 18 F-FDG-PET\/CT images","author":"Kiss","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0035","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41467-025-55847-5","article-title":"Integration of clinical, pathological, radiological, and transcriptomic data improves prediction for first-line immunotherapy outcome in metastatic non-small cell lung cancer","volume":"16","author":"Captier","year":"2025","journal-title":"Nat Commun"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejro.2024.100549","article-title":"Deep learning radiomics model based on PET\/CT predicts PD-L1 expression in non-small cell lung cancer","volume":"12","author":"Li","year":"2024","journal-title":"Eur J Radiol Open"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0037","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-66487-y","article-title":"Automated PD-L1 status prediction in lung cancer with multi-modal PET\/CT fusion","volume":"14","author":"Da-Ano","year":"2024","journal-title":"Sci Rep"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0038","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13550-023-00956-9","article-title":"Predicting PD-L1 expression status in patients with non-small cell lung cancer using [18F]FDG PET\/CT radiomics","volume":"13","author":"Zhao","year":"2023","journal-title":"EJNMMI Res"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.789014","article-title":"Evaluation of PD-L1 expression level in patients with non-small cell lung cancer by 18F-FDG PET\/CT radiomics and clinicopathological characteristics","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0040","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002118","article-title":"Non-invasive measurement of PD-L1 status and prediction of immunotherapy response using deep learning of PET\/CT images","volume":"9","author":"Mu","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0041","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.acra.2019.04.016","article-title":"Assessing PD-L1 expression level by radiomic features from PET\/CT in Nonsmall cell lung cancer patients: an initial result","volume":"27","author":"Jiang","year":"2020","journal-title":"Acad Radiol"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0042","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.21037\/tlcr-24-576","article-title":"Radiomicsmetabolic signature profiles for advanced non-small cell lung cancer with chemoimmunotherapy by reflecting biological function and survival","volume":"13","author":"Jiang","year":"2024","journal-title":"Transl Lung Cancer Res"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0043","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1007\/s00259-019-04625-9","article-title":"Radiomics of 18F-FDG PET\/CT images predicts clinical benefit of advanced NSCLC patients to checkpoint blockade immunotherapy","volume":"47","author":"Mu","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0044","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1186\/s12885-025-13905-7","article-title":"Prediction of pathological complete response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer using 18F-FDG PET radiomics features of primary tumour and lymph nodes","volume":"25","author":"Liu","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0045","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41416-025-02948-z","article-title":"Intratumoral and peritumoral PET\/CT-based radiomics for non-invasively and dynamically predicting immunotherapy response in NSCLC","volume":"132","author":"Lin","year":"2025","journal-title":"Br J Cancer"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0046","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1007\/s00330-023-10503-8","article-title":"[18F]FDG PET-CT radiomics signature to predict pathological complete response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer: a multicenter study","volume":"34","author":"Yang","year":"2023","journal-title":"Eur Radiol"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0047","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.859323","article-title":"A machine learning model based on PET\/CT radiomics and clinical characteristics predicts tumor immune profiles in non-small cell lung cancer: a retrospective multicohort study","volume":"13","author":"Tong","year":"2022","journal-title":"Front Immunol"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0048","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.769272","article-title":"A novel approach using FDG-PET\/CT-based radiomics to assess tumor immune phenotypes in patients with non-small cell lung cancer","volume":"11","author":"Zhou","year":"2021","journal-title":"Front Oncol"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0049","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17111832","article-title":"Radiomic features prognosticate treatment response in CAR-T cell therapy","volume":"17","author":"Balagurunathan","year":"2025","journal-title":"Cancer (Basel)"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0050","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13045-024-01540-x","article-title":"Conventional and novel [18F]FDG PET\/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphoma","volume":"17","author":"Leithner","year":"2024","journal-title":"J Hematol Oncol"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0051","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1485039","article-title":"Radiomic features of PET\/CT imaging of large B cell lymphoma lesions predicts CAR T cell therapy efficacy","volume":"14","author":"Balagurunathan","year":"2024","journal-title":"Front Oncol"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0052","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.1158\/1078-0432.CCR-24-0830","article-title":"Metabolic tumor volume response after bridging therapy determines chimeric antigen receptor T-cell outcomes in large B-cell lymphoma","volume":"30","author":"Hubbeling","year":"2024","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0053","first-page":"1081","article-title":"PET\/CT radiomics for non-invasive prediction of immunotherapy efficacy in cervical cancer","volume":"33","author":"Du","year":"2025","journal-title":"J Xray Sci Technol"},{"key":"10.1053\/j.semnuclmed.2025.11.024_bib0054","article-title":"A PET-CT radiomics model for immunotherapy response and prognosis prediction in patients with metastatic colorectal cancer","volume":"15","author":"Chen","year":"2025","journal-title":"Front Oncol"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000129982500176X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000129982500176X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T05:07:59Z","timestamp":1771218479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000129982500176X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S000129982500176X"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2025.11.024","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PET-CT radiomics for immunotherapy response","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2025.11.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}